EP3033086
Samsett meðferð til meðhöndlunar á krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.8.2014EP published:
22.9.2021EP application number:
14752433.4
EP translation filed:
2.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
6.8.2034Expiry date:
6.8.2026Next due date:
31.8.2026
Title:
COMBINATION THERAPY FOR THE TREATMENT OF CANCER
Timeline
Today
7.8.2014EP application
22.9.2021EP Publication
2.12.2021Translation submitted
15.1.2022Registration published
6.8.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
CHEN, YanAddress:
Cambridge, Massachusetts 02139, US
Name:
HUANG, XizhongAddress:
Cambridge, Massachusetts 02139, US
Name:
KIM, SunkyuAddress:
Cambridge, Massachusetts 02139, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361865804 PDate:
14.8.2013Country:
US
Number:
201361894029 PDate:
22.10.2013Country:
US
Classification
Categories:
A61K 31/519, A61K 31/551, A61K 45/06, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 27.7.2022
Expires: 6.8.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 26.7.2023
Expires: 6.8.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 23.7.2024
Expires: 6.8.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.8.2025
Expires: 6.8.2026
Payer: Árnason Faktor ehf.